Sirona Medical Raises $40M Series D as Platform Usage Triples
Round led by Avidity Partners. Platform usage, ARR, & contracted ARR all grew by more than 2.5x year-over-year.…
New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
Oracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research Initiative
Buck Institute aims to advance bioinformatics using Oracle Life Sciences Data Intelligence to transform aging research into a…
Mindoula Expands Whole Person Care Enablement Platform Through Strategic Acquisitions
“The combination of Mindoula, Valera, and Janus gives both our existing partners and new partners the opportunity to…
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
Employee Well-Being Slips as Financial Stress Surges, Survey Finds
More than 1 in 4 employees report low well-being, according to a new report from WebMD Health Services. PORTLAND, Ore., June 18,…
Not Just a Headache: Year Three of Pfizer’s OOO for Migraine Awareness Campaign Aims to Make Migraine a Visible Priority at Work
Pfizer Canada, Migraine Canada, and Migraine Québec continue partnership to educate Canadians on the impact of migraine. Increasing…
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach…
Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®
MISSISSAUGA, ON, May 26, 2026 /CNW/ – Novo Nordisk Canada is announcing that effective Friday, May 29, 2026,…
Vi Launches Suite of AI Agents for Healthcare, Life Sciences, and Wellness Enterprises; Completes $145M Transaction at $1.64B Valuation
NEW YORK, May 19, 2026 /PRNewswire/ — Vi, the enterprise-AI platform for health, today announced a new suite…
Canada Facing $17.6 Billion Kidney Disease Crisis by 2050; Kidney Foundation Calls for Early Detection to Save Lives and Reduce Health Care Spending
New Deloitte report commissioned by The Kidney Foundation of Canada calls for early intervention to prevent up to…